Skip to main content
Equibles

Steward Partners Investment Advisory, LLC

Position in SCLX — Scilex Holding Co

CIK 1723397 STAMFORD, CT
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$62
+$9 QoQ
Shares Held
8
-38.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Steward Partners Investment Advisory, LLC holds $502,917,200 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 116,568 $139,815,167
2 ABBV
AbbVie Inc.
 475,389 $119,626,887
3 JNJ
Johnson & Johnson
 461,457 $117,196,234
4 MRK
Merck & Co., Inc.
 318,918 $40,980,963
5 AMGN
Amgen Inc
 79,642 $28,839,961
6 BMY
Bristol Myers Squibb Co
 277,131 $15,968,288
7 PFE
Pfizer Inc
 520,623 $12,536,601
8 GILD
Gilead Sciences, Inc.
 66,698 $8,426,625

All Filings in SCLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62 8
2026-03-31 $53 8
2025-12-31 $109 9
2025-09-30 $177 9
2025-06-30 $53 9
2025-03-31 $157 634
2024-12-31 $536 1,260
2024-09-30 $586 634
2024-06-30 $1,223 634
2024-03-31 $1,008 634
2023-12-31 $1,293 634
2023-09-30 $887 634
2023-06-30 $3,531 634
2023-03-31 $5,198 634